Hanchen Lee

This inventor holds 4 USPTO granted patents, plus 1 CIPO patent and 2 EPO patents. Top assignees: Array Biopharma Inc., Novartis Ag. Active years: 2016-2020.

USPTO Granted Patents = 4

% Patents Active = 100.0

CIPO Patents = 1

EPO Patents = 2 (Patent Applications = 2)

Average Co-Inventor Count = 7.0

ph-index = 2

Forward Citations = 19(Granted Patents)

Company Filing History:

Years Active: 2016-2020

Loading Chart...

4 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 10561654 - Pharmaceutical formulations of (S)-methyl(1-((4-(3-(5-chloro-2-fluoro-3-(methylsulfonamido)phenyl)-1-isopropyl-1H-pyrazol-4-yl)pyrimidin-2-yl)amino)propan-2-yl)carbamate (2020-02-18),

2. 10258622 - Method of treating colorectal cancer by administration of pharmaceutical formulations of (S)-methyl (1-((4-(3-(5-chloro-2-fluoro-3-(methylsulfonamido)pheny1)-1-isopropyl-1H-pyrazol-4-yl)pyrimidin-2-yl)amino)propan-2-yl) carbamate (2019-04-16),

3. 9763941 - Method of treating melanoma by administration of pharmaceutical formulations of (S)-methyl (1-((4-(3-(5-chloro-2-fluoro-3-(methylsulfonamido)phenyl)-1-isopropyl-1H-pyrazol-4-yl)pyrimidin-2-yl)amino)propan-2-yl)carbamate (2017-09-19),

4. 9387208 - Pharmaceutical formulations of (S)-methyl (1-((4-(3-(5-chloro-2-fluoro-3-(methylsulfonamido)phenyl)-1-isopropyl-1H-pyrazol-4-yl)pyrimidin-2-yl)amino)propan-2-yl)carbamate (2016-07-12),

This text is generated by artificial intelligence and may not be accurate.

Please report any incorrect information to [email protected]

1 patent (CIPO):

Please report any incorrect information to [email protected]

2 patents (EPO):

Please report any incorrect information to [email protected]

2 patents pending (EPO):

Please report any incorrect information to [email protected]